BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30414350)

  • 1. Platinum(II) Complexes with 1,10-Phenanthroline and Hydrophilic Alkoxyacetate Ligands as Potential Antitumor Agents.
    Sun Y; Wei H; Zhang Q; Zhao X
    Chem Biodivers; 2019 Jan; 16(1):e1800373. PubMed ID: 30414350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
    Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
    Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dinuclear platinum(II) complexes of imidazophenanthroline-based bridging ligands as potential anticancer agents: synthesis, characterization, and in vitro cytotoxicity studies.
    Alexander C; Prajith NU; Priyanka PV; Nithyakumar A; Arockia Samy N
    J Biol Inorg Chem; 2019 May; 24(3):405-418. PubMed ID: 30945024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
    Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
    Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
    Zhou Z; Chen F; Xu G; Gou S
    Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, in vitro cytotoxicity, and interaction with DNA of platinum(II) complexes with N-monocycloalkyl derivatives of 1R,2R-diaminocyclohexane as carrier ligands.
    Sun Y; Gou S; Liu F; Yin R; Fang L
    ChemMedChem; 2012 Apr; 7(4):642-9. PubMed ID: 22247027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
    Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
    Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, spectral characterization of novel Pd(II), Pt(II) π-coordination compounds based on N-allylthioureas. Cytotoxic properties and DNA binding ability.
    Repich HH; Orysyk VV; Palchykovska LG; Orysyk SI; Zborovskii YL; Vasylchenko OV; Storozhuk OV; Biluk AA; Nikulina VV; Garmanchuk LV; Pekhnyo VI; Vovk MV
    J Inorg Biochem; 2017 Mar; 168():98-106. PubMed ID: 28086144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
    Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
    J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
    Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
    J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
    Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
    Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N,N-Dialkylbenzimidazol-2-ylidene platinum complexes - effects of alkyl residues and ancillary cis-ligands on anticancer activity.
    Rehm T; Rothemund M; Bär A; Dietel T; Kempe R; Kostrhunova H; Brabec V; Kasparkova J; Schobert R
    Dalton Trans; 2018 Dec; 47(48):17367-17381. PubMed ID: 30480671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ni(ii)/Cu(ii)/Zn(ii) 5,5-diethylbarbiturate complexes with 1,10-phenanthroline and 2,2'-dipyridylamine: synthesis, structures, DNA/BSA binding, nuclease activity, molecular docking, cellular uptake, cytotoxicity and the mode of cell death.
    Yilmaz VT; Icsel C; Suyunova F; Aygun M; Aztopal N; Ulukaya E
    Dalton Trans; 2016 Jun; 45(25):10466-79. PubMed ID: 27263797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
    Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
    Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic and apoptotic effects of ternary silver(i) complexes bearing 2-formylpyridine thiosemicarbazones and 1,10-phenanthroline.
    Silva DES; Becceneri AB; Solcia MC; Santiago JVB; Moreira MB; Gomes Neto JA; Pavan FR; Cominetti MR; Pereira JCM; Netto AVG
    Dalton Trans; 2020 Apr; 49(16):5264-5275. PubMed ID: 32242564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembly of novel molecular complexes of 1,10-phenanthroline and 5-amino-1,10-phenanthroline and evaluation of their in vitro antitumour activity.
    Kaloyanov N; Alexandrova R; Wesselinova DW; Mayer-Figge H; Sheldrick WS; Dimitrov GD
    Eur J Med Chem; 2011 Jun; 46(6):1992-6. PubMed ID: 21474217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsymmetrical oxovanadium complexes derived from salicylaldehyde and phenanthroline: synthesis, DNA interactions, and antitumor activities.
    Liao X; Pan W; He R; Guo H; Ying P; Lu J
    Chem Biol Drug Des; 2014 Mar; 83(3):367-78. PubMed ID: 24118856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.